Zobrazeno 1 - 10
of 186
pro vyhledávání: '"59"'
Autor:
Peter J. Sterk, Nazanin Zounemat Kermani, Ian M. Adcock, Pascal Chanez, Florian Singer, Stewart Bates, Magnus Ericsson, John H. Riley, Jessica Lasky-Su, Romanas Chaleckis, Ildiko Horvath, Hector Gallart-Ayala, Stephen J. Fowler, Craig E. Wheelock, Norbert Krug, Henric Olsson, Stacey N. Reinke, Jacek Musiał, Peter H. Howarth, Matthew J. Loza, Kian Fan Chung, Barbro Dahlén, Thomas Geiser, Massimo Caruso, David I. Broadhurst, Cristina Gómez, Dominick E. Shaw, Johan Kolmert, Per Bakke, Angelica Tiotiu, Paolo Montuschi, Sile Hu, Ratko Djukanovic, Ana R. Sousa, Sven-Erik Dahlén, Frédéric Baribaud, James Scholfield, Shama Naz, Åsa M. Wheelock, Anders Lundqvist, Annelie F. Behndig, Marika Ström
Publikováno v:
European Respiratory Journal
Reinke, Stacey N; Naz, Shama; Chaleckis, Romanas; Gallart-Ayala, Hector; Kolmert, Johan; Kermani, Nazanin Z; Tiotiu, Angelica; Broadhurst, David I; Lundqvist, Anders; Olsson, Henric; Ström, Marika; Wheelock, Åsa M; Gómez, Cristina; Ericsson, Magnus; Sousa, Ana R; Riley, John H; Bates, Stewart; Scholfield, James; Loza, Matthew; Baribaud, Frédéric; ... (2022). Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study. European respiratory journal, 59(6) European Respiratory Society 10.1183/13993003.01733-2021
Reinke, S N, Naz, S, Chaleckis, R, Gallart-Ayala, H, Kolmert, J, Kermani, N Z, Tiotiu, A, Broadhurst, D I, Lundqvist, A, Olsson, H, Ström, M, Wheelock, Å M, Gómez, C, Ericsson, M, Sousa, A R, Riley, J H, Bates, S, Scholfield, J, Loza, M, Baribaud, F, Bakke, P S, Caruso, M, Chanez, P, Fowler, S J, Geiser, T, Howarth, P, Horváth, I, Krug, N, Montuschi, P, Behndig, A, Singer, F, Musial, J, Shaw, D E, Dahlén, B, Hu, S, Lasky-Su, J, Sterk, P J, Chung, K F, Djukanovic, R, Dahlén, S-E, Adcock, I M & Wheelock, C E 2021, ' Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study ', The European respiratory journal . https://doi.org/10.1183/13993003.01733-2021
European respiratory journal, 59(6):01733. European Respiratory Society
European Respiratory Journal, 2021, pp.2101733. ⟨10.1183/13993003.01733-2021⟩
Reinke, Stacey N; Naz, Shama; Chaleckis, Romanas; Gallart-Ayala, Hector; Kolmert, Johan; Kermani, Nazanin Z; Tiotiu, Angelica; Broadhurst, David I; Lundqvist, Anders; Olsson, Henric; Ström, Marika; Wheelock, Åsa M; Gómez, Cristina; Ericsson, Magnus; Sousa, Ana R; Riley, John H; Bates, Stewart; Scholfield, James; Loza, Matthew; Baribaud, Frédéric; ... (2022). Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study. European respiratory journal, 59(6) European Respiratory Society 10.1183/13993003.01733-2021
Reinke, S N, Naz, S, Chaleckis, R, Gallart-Ayala, H, Kolmert, J, Kermani, N Z, Tiotiu, A, Broadhurst, D I, Lundqvist, A, Olsson, H, Ström, M, Wheelock, Å M, Gómez, C, Ericsson, M, Sousa, A R, Riley, J H, Bates, S, Scholfield, J, Loza, M, Baribaud, F, Bakke, P S, Caruso, M, Chanez, P, Fowler, S J, Geiser, T, Howarth, P, Horváth, I, Krug, N, Montuschi, P, Behndig, A, Singer, F, Musial, J, Shaw, D E, Dahlén, B, Hu, S, Lasky-Su, J, Sterk, P J, Chung, K F, Djukanovic, R, Dahlén, S-E, Adcock, I M & Wheelock, C E 2021, ' Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study ', The European respiratory journal . https://doi.org/10.1183/13993003.01733-2021
European respiratory journal, 59(6):01733. European Respiratory Society
European Respiratory Journal, 2021, pp.2101733. ⟨10.1183/13993003.01733-2021⟩
IntroductionAsthma is a heterogeneous disease with poorly defined phenotypes. Patients with severe asthma often receive multiple treatments including oral corticosteroids (OCS). Treatment may modify the observed metabotype, rendering it challenging t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e44649ee35b8f7c945ee381b8be1f1
https://hdl.handle.net/11250/3025378
https://hdl.handle.net/11250/3025378
Autor:
Alicia K. Gerke, Aaron C. Miller, Joseph E. Cavanaugh, Douglas B. Hornick, Alejandro P. Comellas, David A. Stoltz, Michael J. Welsh, Joseph Zabner, Philip M. Polgreen
Publikováno v:
Proceedings of the National Academy of Sciences. 117:1621-1627
Autosomal recessive diseases, such as cystic fibrosis (CF), require inheritance of 2 mutated genes. However, some studies indicate that CF carriers are at increased risk for some conditions associated with CF. These investigations focused on single c
Autor:
Berengere Gruson, Taieb Chouaki, Xavier Cazals, Olivier Lortholary, Claire Rivoisy, Marie-Elisabeth Bougnoux, Fanny Lanternier, Louis Bernard, Fabrice Chrétien, Grégory Jouvion, Agnès Lefort, Guillaume Desoubeaux, Marie Desnos-Ollivier, Hélène Chaussade
Publikováno v:
Medical Mycology
Medical Mycology, 2021, 59 (3), pp.266-277. ⟨10.1093/mmy/myaa051⟩
Medical Mycology, Oxford University Press, 2021, 59 (3), pp.266-277. ⟨10.1093/mmy/myaa051⟩
Medical Mycology, 2021, 59 (3), pp.266-277. ⟨10.1093/mmy/myaa051⟩
Medical Mycology, Oxford University Press, 2021, 59 (3), pp.266-277. ⟨10.1093/mmy/myaa051⟩
Though candidiasis is the most frequent invasive fungal infection, Candida spp. central nervous system (CNS) infections are rare but severe. To further describe clinico-patho-radiological presentations of this entity, we report a retrospective study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14f87564ab84c1b09b503af76e13adc7
https://hal-pasteur.archives-ouvertes.fr/pasteur-03243538
https://hal-pasteur.archives-ouvertes.fr/pasteur-03243538
Autor:
Philippe Moulin, Jocelyne Drai, Emmanuelle Reboul, Emile Levy, Charlotte Cuerq, Lioara Restier, Noël Peretti, Mathilde Di Filippo, Marie-Caroline Michalski, Alain Lachaux, Emilie Blond, Pierre Poinsot, Agnès Sassolas, Sybil Charrière, Cyrielle Caussy, Christian Laveille, Christophe Marçais, Emilie Henin
Publikováno v:
Journal of Lipid Research
Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 2018, 59 (9), pp.1640--1648
Journal of Lipid Research, 2018, 59 (9), pp.1640-1648. ⟨10.1194/jlr.M085043⟩
Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 2018, 59 (9), pp.1640-1648. ⟨10.1194/jlr.M085043⟩
Journal of Lipid Research, Vol 59, Iss 9, Pp 1640-1648 (2018)
Journal of Lipid Research, 2018, 59 (9), pp.1640--1648
Journal of Lipid Research 9 (59), 1640-1648. (2018)
Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 2018, 59 (9), pp.1640--1648
Journal of Lipid Research, 2018, 59 (9), pp.1640-1648. ⟨10.1194/jlr.M085043⟩
Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 2018, 59 (9), pp.1640-1648. ⟨10.1194/jlr.M085043⟩
Journal of Lipid Research, Vol 59, Iss 9, Pp 1640-1648 (2018)
Journal of Lipid Research, 2018, 59 (9), pp.1640--1648
Journal of Lipid Research 9 (59), 1640-1648. (2018)
International audience; Abetalipoproteinemia (ABL) and chylomicron retention disease (CMRD) are extremely rare recessive forms of hypobetalipoproteinemia characterized by intestinal lipid malabsorption and severe vitamin E deficiency. Vitamin E is of
Autor:
Florence Uettwiller, Makoto Miyara, François-Jérôme Authier, Maria José Martin-Niclos, Pierre Quartier, Alice Lepelley, Nicole Fabien, Alexandre Belot, Yanick J. Crow, Alice Hadchouel, Isabelle Melki, Emmanuelle Bourrat, Albert Faye, Darragh Duffy, Theresa Kwon, Brigitte Bader-Meunier, Carolina Uggenti, Sasi Mudumba, Lucile Musset, Gillian I. Rice, Vincent Bondet, Jean-Luc Charuel, Cyril Gitiaux, Naoki Kitabayashi, Cécile Dumaine, Marie-Louise Frémond, Christine Bodemer, Luis Seabra, Sébastien Viel, Plamen Bokov, Mathieu P Rodero, Yves Allenbach, Hervé Devilliers, Ahmed Kheniche
Publikováno v:
Rheumatology
Rheumatology, Oxford University Press (OUP), 2020, 59 (8), pp.1927-1937. ⟨10.1093/RHEUMATOLOGY/KEZ525⟩
Rheumatology, Oxford University Press (OUP), 2020, 59 (8), pp.1927-1937. ⟨10.1093/rheumatology/kez525⟩
Rheumatology, 2020, 59 (8), pp.1927-1937. ⟨10.1093/rheumatology/kez525⟩
Melki, I, Devilliers, H, Gitiaux, C, Bondet, V, Duffy, D, Charuel, J-L, Miyara, M, Bokov, P, Kheniche, A, Kwon, T, Authier, F-J, Allenbach, Y, Belot, A, Bodemer, C, Bourrat, E, Dumaine, C, Fabien, N, Faye, A, Frémond, M-L, Hadchouel, A, Kitabayashi, N, Lepelley, A, Martin-Niclos, M J, Mudumba, S, Musset, L, Quartier, P, Rice, G I, Seabra, L, Uettwiller, F, Uggenti, C, Viel, S, Rodero, M P, Crow, Y & Bader-Meunier, B 2019, ' Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling ', Rheumatology . https://doi.org/10.1093/rheumatology/kez525
Melki, I, Devilliers, H, Gitiaux, C, Bondet, V, Duffy, D, Charuel, J-L, Miyara, M, Bokov, P, Kheniche, A, Kwon, T, Authier, F J, Allenbach, Y, Belot, A, Bodemer, C, Bourrat, E, Dumaine, C, Fabien, N, Faye, A, Frémond, M-L, Hadchouel, A, Kitabayashi, N, Lepelley, A, Martin-Niclos, M J, Mudumba, S, Musset, L, Quartier, P, Rice, G I, Seabra, L, Uettwiller, F, Uggenti, C, Viel, S, Rodero, M P, Crow, Y J & Bader-Meunier, B 2020, ' Anti-MDA5 juvenile idiopathic inflammatory myopathy : a specific subgroup defined by differentially enhanced interferon-α signalling ', Rheumatology (Oxford, England) . https://doi.org/10.1093/rheumatology/kez525
Rheumatology, Oxford University Press (OUP), 2020, 59 (8), pp.1927-1937. ⟨10.1093/RHEUMATOLOGY/KEZ525⟩
Rheumatology, Oxford University Press (OUP), 2020, 59 (8), pp.1927-1937. ⟨10.1093/rheumatology/kez525⟩
Rheumatology, 2020, 59 (8), pp.1927-1937. ⟨10.1093/rheumatology/kez525⟩
Melki, I, Devilliers, H, Gitiaux, C, Bondet, V, Duffy, D, Charuel, J-L, Miyara, M, Bokov, P, Kheniche, A, Kwon, T, Authier, F-J, Allenbach, Y, Belot, A, Bodemer, C, Bourrat, E, Dumaine, C, Fabien, N, Faye, A, Frémond, M-L, Hadchouel, A, Kitabayashi, N, Lepelley, A, Martin-Niclos, M J, Mudumba, S, Musset, L, Quartier, P, Rice, G I, Seabra, L, Uettwiller, F, Uggenti, C, Viel, S, Rodero, M P, Crow, Y & Bader-Meunier, B 2019, ' Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling ', Rheumatology . https://doi.org/10.1093/rheumatology/kez525
Melki, I, Devilliers, H, Gitiaux, C, Bondet, V, Duffy, D, Charuel, J-L, Miyara, M, Bokov, P, Kheniche, A, Kwon, T, Authier, F J, Allenbach, Y, Belot, A, Bodemer, C, Bourrat, E, Dumaine, C, Fabien, N, Faye, A, Frémond, M-L, Hadchouel, A, Kitabayashi, N, Lepelley, A, Martin-Niclos, M J, Mudumba, S, Musset, L, Quartier, P, Rice, G I, Seabra, L, Uettwiller, F, Uggenti, C, Viel, S, Rodero, M P, Crow, Y J & Bader-Meunier, B 2020, ' Anti-MDA5 juvenile idiopathic inflammatory myopathy : a specific subgroup defined by differentially enhanced interferon-α signalling ', Rheumatology (Oxford, England) . https://doi.org/10.1093/rheumatology/kez525
Objectives JDM and juvenile overlap myositis represent heterogeneous subtypes of juvenile idiopathic inflammatory myopathy (JIIM). Chronic evolution can occur in up to 60% of cases, and morbidity/mortality is substantial. We aimed to describe the cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a37a26927293cef084123419c8adb1
https://hal.archives-ouvertes.fr/hal-02996374
https://hal.archives-ouvertes.fr/hal-02996374
Autor:
Xavier Troussard, Agnès Olivrie, Gandhi Damaj, Stephanie Noel, Jean-Claude Eisenmann, Olivier Hermine, Jérémie Riou, Sandrine Vaudaux, Patricia Validire-Charpy, Jean Gutnecht, Alain Devidas, Charlotte Petitdidier-Lionnet, Mohamed Touati, Stephanie Haiat, Vincent Levy, Fabienne Huysman, Eric Lippert, Aline Tanguy-Schmidt, Jehan Dupuis, Olivier Lambotte, Clara Mariette, Marouane Boubaya, Edouard Cornet, Pierre Feugier, Mathilde Hunault-Berger, Bertrand Joly, Stéphane Leprêtre, Jérôme Paillassa, Cécile Tomowiak, Kamel Ghomari, Willy Vaillant, Catherine Thieblemont, Mario Ojeda Uribe, Didier Decaudin, Bernard Drenou, Jean-Michel Karsenti
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Nature Publishing Group, 2020, 10 (5), pp.62. ⟨10.1038/s41408-020-0328-z⟩
Blood Cancer Journal, 2020, 10 (5), pp.62. ⟨10.1038/s41408-020-0328-z⟩
Blood Cancer Journal, Vol 10, Iss 5, Pp 1-12 (2020)
Blood Cancer Journal, Nature Publishing Group, 2020, 10 (5), pp.62. ⟨10.1038/s41408-020-0328-z⟩
Blood Cancer Journal, 2020, 10 (5), pp.62. ⟨10.1038/s41408-020-0328-z⟩
Blood Cancer Journal, Vol 10, Iss 5, Pp 1-12 (2020)
In total, 279 patients with hairy-cell leukemia (HCL) were analyzed, with a median follow-up of 10 years. Data were collected up to June 2018. We analyzed responses to treatment, relapses, survival, and the occurrence of second malignancies during fo
Autor:
Snežana Brkić, Ivana Gušić, Aleksandra Maletin, Saša Čakić, Tanja Veljović, Jelena Mirnic, Milanko Đurić
Publikováno v:
Acta Clinica Croatica
Acta clinica Croatica
Volume 59.
Issue 4.
Acta Clinica Croatica, Vol 59., Iss 4., Pp 615-621 (2020)
Acta clinica Croatica
Volume 59.
Issue 4.
Acta Clinica Croatica, Vol 59., Iss 4., Pp 615-621 (2020)
The 8-hydroxy-deoxyguanosine (8-OHdG) is one of the customary products of oxidized DNA. The purpose of this study was to compare salivary and plasma 8-OHdG concentrations in a group of chronic periodontitis patients to those measured in a group of pa
Autor:
Marie, Danielou, Hélène, Sarter, Benjamin, Pariente, Mathurin, Fumery, Delphine, Ley, Christel, Mamona, Maël, Barthoulot, Cloé, Charpentier, Laurent, Siproudhis, Guillaume, Savoye, Corinne, Gower-Rousseau, C, Ziade
Publikováno v:
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, 2019, pp.jjz173. ⟨10.1093/ecco-jcc/jjz173⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2019, pp.jjz173. ⟨10.1093/ecco-jcc/jjz173⟩
Journal of Crohn's and Colitis, 2019, pp.jjz173. ⟨10.1093/ecco-jcc/jjz173⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2019, pp.jjz173. ⟨10.1093/ecco-jcc/jjz173⟩
Introduction Most studies of elderly-onset Crohn’s disease [CD; diagnosed in patients aged 60 or over] have described a mild course. However, data on the natural history of perianal fistulising CD [pfCD] in this population are scarce. In a populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e56f1a77bf192fd2d4e19d71e26a9a5
https://hal-normandie-univ.archives-ouvertes.fr/hal-02465859
https://hal-normandie-univ.archives-ouvertes.fr/hal-02465859
Autor:
Daniël H. van Raalte, Michaela Diamant, Mark M. Smits, Marcel H. A. Muskiet, Lennart Tonneijck, Jaap A. Joles, A.H. Jan Danser, Trynke Hoekstra, Mark H. H. Kramer
Publikováno v:
Diabetologia, 59(7), 1412-1421. Springer-Verlag
Diabetologia
Diabetologia, 59(7), 1412. Springer Verlag
Diabetologia, 59(7), 1412-1421. Springer Verlag
Diabetologia, 59(7), 1412-21. Springer Verlag
Tonneijck, L, Smits, M M, Muskiet, M H A, Hoekstra, T, Kramer, M H H, Danser, A H J, Diamant, M, Joles, J A & van Raalte, D H 2016, ' Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial ', Diabetologia, vol. 59, no. 7, pp. 1412-1421 . https://doi.org/10.1007/s00125-016-3938-z
Tonneijck, L, Smits, M M, Muskiet, M H A, Hoekstra, T, Kramer, M H H, Danser, A H J, Diamant, M, Joles, J A & van Raalte, D H 2016, ' Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients : a randomised, double-blind, placebo-controlled trial ', Diabetologia, vol. 59, no. 7, pp. 1412-21 . https://doi.org/10.1007/s00125-016-3938-z
Diabetologia
Diabetologia, 59(7), 1412. Springer Verlag
Diabetologia, 59(7), 1412-1421. Springer Verlag
Diabetologia, 59(7), 1412-21. Springer Verlag
Tonneijck, L, Smits, M M, Muskiet, M H A, Hoekstra, T, Kramer, M H H, Danser, A H J, Diamant, M, Joles, J A & van Raalte, D H 2016, ' Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial ', Diabetologia, vol. 59, no. 7, pp. 1412-1421 . https://doi.org/10.1007/s00125-016-3938-z
Tonneijck, L, Smits, M M, Muskiet, M H A, Hoekstra, T, Kramer, M H H, Danser, A H J, Diamant, M, Joles, J A & van Raalte, D H 2016, ' Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients : a randomised, double-blind, placebo-controlled trial ', Diabetologia, vol. 59, no. 7, pp. 1412-21 . https://doi.org/10.1007/s00125-016-3938-z
Aims/hypothesis This study aimed to investigate the acute renal effects of the glucagon-like peptide-1 receptor agonist (GLP-1RA) exenatide in type 2 diabetes patients. Methods We included overweight (BMI 25–40 kg/m2) men and postmenopausal women,
Autor:
David B. Meya, Micheal Okirwoth, Richard Kwizera, Ananta S Bangdiwala, Fiona V Cresswell, Enock Kagimu, Darlisha A. Williams, Gerald Mugumya, David R. Boulware, Joshua Rhein
Publikováno v:
Wellcome Open Research. 4:123
Background: The diagnostic utility of the Mycobacteria tuberculosis lipoarabinomannan (TB-LAM) antigen lateral flow assay on cerebrospinal fluid (CSF) for the diagnosis of tuberculous meningitis (TBM) has not been extensively studied and the few publ